EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer

About 70% of all breast cancers are estrogen receptor alpha positive (ER+; ESR1). Many are treated with antiestrogens. Unfortunately, de novo and acquired resistance to antiestrogens is common but the underlying mechanisms remain unclear. Since growth of cancer cells is dependent on adequate energy...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Shajahan-Haq, Ayesha N., Boca, Simina M., Jin, Lu, Bhuvaneshwar, Krithika, Gusev, Yuriy, Cheema, Amrita K., Demas, Diane D., Raghavan, Kristopher S., Michalek, Ryan, Madhavan, Subha, Clarke, Robert
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2017
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5722529/
https://ncbi.nlm.nih.gov/pubmed/29228577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18292
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg